Home/Filings/4/0001600620-23-000042
4//SEC Filing

Foster Robert T 4

Accession 0001600620-23-000042

CIK 0001600620other

Filed

Sep 21, 8:00 PM ET

Accepted

Sep 22, 4:36 PM ET

Size

7.4 KB

Accession

0001600620-23-000042

Insider Transaction Report

Form 4
Period: 2023-09-21
Transactions
  • Award

    Restricted Stock Units

    2023-09-21+20,38320,383 total
    Common Stock (20,383 underlying)
  • Award

    Stock Option (right to buy)

    2023-09-21+32,90032,900 total
    Exercise: $8.34Exp: 2033-09-21Common Stock (32,900 underlying)
Footnotes (3)
  • [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]The RSUs will vest one year from date of grant and have no expiration date. Vested shares will be delivered on September 21, 2024
  • [F3]The option vests in twelve equal monthly installments commencing on October 21, 2023.

Issuer

Aurinia Pharmaceuticals Inc.

CIK 0001600620

Entity typeother

Related Parties

1
  • filerCIK 0001677370

Filing Metadata

Form type
4
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 4:36 PM ET
Size
7.4 KB